ICH M10 guideline - a harmonized global approach to bioanalysis

Elżbieta Gniazdowska; Edyta Gilant; Katarzyna Buś-Kwaśnik

doi:10.56782/pps.152

Published : 2023-09-22

Vol. 21 No. 3 (2023)

ICH M10 guideline - a harmonized global approach to bioanalysis

Elżbieta Gniazdowska

Edyta Gilant

Katarzyna Buś-Kwaśnik

DOI: https://doi.org/10.56782/pps.152

Abstract

Bioanalytical methods are used in research on small-molecule and large-molecule drug products to determine analytes and their metabolites in biological matrices such as blood, plasma, serum, urine, feces, saliva, other biological fluids, or tissues. Validation of a bioanalytical method is the essential step before the implementation of the method into routine use in toxicokinetic or pharmacokinetic studies. Harmonization of recommendations for the validation of bioanalytical methods has been advocated for many years. In 2022, The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) finished the work on final version of the ICH M10 guideline, as a combination of four regional guidelines (American, European, Brazilian and Japanise). The document uniforms rules for the performance of the bioanalytical method validation and documentation of sample analysis from clinical and non-clinical studies in most countries around the world, which are submitted to registration authorities.

Keywords:

bioanalytical method validation, reliability, harmonization, bioavailability, pharmacokinetics

Similar Articles

Łukasz Szeleszczuk, Marzena Kuras, THE ROLE OF CALCIUM IN HUMAN METABOLISM AND FACTORS AFFECTING ITS BIOAVAILABILITY , Prospects in Pharmaceutical Sciences: Vol. 12 No. 3 (2014)
Błażej Grodner, Małgorzata Jelińska, The method of direct determination of manganese in fresh parsley leaves and roots using capillary electrophoresis method. , Prospects in Pharmaceutical Sciences: Vol. 21 No. 1 (2023)
Magdalena Makarewicz, Anna Łysiak, Katarzyna Łysiak, Barbara Maziarz, Evaluation of the effectiveness of platelet-rich plasma therapy in the treatment of osteoarthritis compared to other treatment methods , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Bartłomiej Kot, Mateusz Moczulski, Agnieszka Czajkowska, Arkadiusz Kocur, Pharmacotherapy of apnea in the premature neonatological subpopulation – therapeutic opportunities, pharmacokinetic implications and recommendations for therapeutic drug monitoring , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Bartłomiej Pyrak, Tomasz Gubica, Karolina Rogacka-Pyrak, Cyclodextrin nanosponges as bioenhancers of phytochemicals , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Jadwiga Piwowarska, Jolanta Felczak, Jacek Łukaszkiewicz, CONCENTRATION OF MALONDIALDEHYDE IN BLOOD AS AN INDICATOR IN LIVER TRANSPLANTATION , Prospects in Pharmaceutical Sciences: Vol. 14 No. 6 (2016)
Ali İmran Korkmaz, Celal Bal, Emre Cem Eraslan, Mustafa Sevindik, Hasan Akgul, Biological activities of Agrocybe praecox (spring fieldcap mushroom) , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Magdalena Bamburowicz-Klimkowska, Urszula Bogucka, Mirosław M. Szutowski, FUNCTIONS OF ATP-BINDING CASSETTE (ABC) TRANSPORTERS , Prospects in Pharmaceutical Sciences: Vol. 9 No. 3 (2011)
Martyna Chechłacz, Natalia Korytowska, COMPOUNDS THAT BIND TO PLASMA PROTEINS IN HUMANS. SIGNIFICANCE IN THERAPY AND METHODS FOR QUANTIFICATION OF A FREE FRACTION , Prospects in Pharmaceutical Sciences: Vol. 15 No. 6 (2017)
Ali İmran Korkmaz, Celal Bal, Tetiana Krupodorova, Mehmet Ali Yüzbaşıoğlu, Beste Gizem Özbey Sarıdoğan, Mustafa Sevindik, Some biological activities and element levels of Lycoperdon pratense , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)

1 2 3 4 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Gniazdowska, E., Gilant, E., & Buś-Kwaśnik, K. (2023). ICH M10 guideline - a harmonized global approach to bioanalysis. Prospects in Pharmaceutical Sciences, 21(3), 57–63. https://doi.org/10.56782/pps.152

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

European Medicines Agency, ICH guideline M10 on bioanalytical method validation and study sample analysis, 2022.

European Medicines Agency (EMA), Committee for Medicinal Product for Human Use (CHMP), Guideline on Bioanalytical Method Validation, 2011.

U.S. Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, 2018.

European Medicines Agency, ICH guideline M4 (R4) on common technical document, Amsterdam, 19 March 2021. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m4-r4-common-technical-document-ctd-registration-pharmaceuticals-human-use_en.pdf (data dostępu: 28.08.2023).

ANVISA, Ministry of Health, National Health Surveillance Agency, Resolution- RDC NO. 27 OF 17 MAY 2012, 2012.

Ministry of Health, Labour and Welfare (MHLW) of Japan. Guideline on Bioanalytical Method Validation in Pharmaceutical Development (25 July 2013, MHLW, Japan). http://www.nihs.go.jp/drug/BMV/250913_BMV-GL_E.pdf (data dostępu: 28.08.2023).

The Ministry of Health, Labour and Welfare (MHLW) of Japan. Guideline on Bioanalytical Method. (Ligand Binding Assay) Validation in Pharmaceutical Development. (1 April, 2014, MHLW, Japan), 2014.

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Final endorsed Concept Paper M10: Bioanalytical Method Validation. 7 October 2016. https://database.ich.org/sites/default/files/M10EWG_Concept_Paper.pdf (data dostępu: 28.08.2023).

Timmerman, P.; Lowes, S.; Fast, D.M.; Garofolo, F. Request for Global Harmonization of the Guidance for Bioanalytical Method Validation and Sample Analysis. Bioanalysis 2010, 2, 683-683, doi:10.4155/bio.10.34. DOI: https://doi.org/10.4155/bio.10.34

Bansal, S.K.; Arnold, M.; Garofolo, F. International harmonization of bioanalytical guidance. Bioanalysis 2010, 2, 685-687, doi:10.4155/bio.10.39. DOI: https://doi.org/10.4155/bio.10.39

The 3Rs. https://www.nc3rs.org.uk/who-we-are/3rs (data dostępu: 28.08.2023).

Overcoming of ongoing ICH Topics – ICH Public Meeting Amsterdam 042919. https://www.fda.go/media/124548/download (data dostępu: 28.08.2023).

ICH Guideline Implementation. https://www.ich.org/page/ich-guideline-implementation (data dostępu: 28.08.2023).

Ingelse, B.; Barroso, B.; Gray, N.; Jakob-Rodamer, V.; Kingsley, C.; Sykora, C.; Vinck, P.; Wein, M.; White, S. European Bioanalysis Forum: recommendation on dealing with hemolyzed and hyperlipidemic matrices. Bioanalysis 2014, 6, 3113-3120, doi:10.4155/bio.14.252. DOI: https://doi.org/10.4155/bio.14.252

Briscoe, C.J.; Hage, D.S. Factors affecting the stability of drugs and drug metabolites in biological matrices. Bioanalysis 2009, 1, 205-220, doi:10.4155/bio.09.20. DOI: https://doi.org/10.4155/bio.09.20

European Medicines Agency. ICH guideline M10 on bioanalytical method validation and study sample analysis - Questions and Answers. (EMA/CHMP/ICH/660315/2022), 2023.

Zwart, M.d.; Lausecker, B.; Globig, S.; Neddermann, D.; Bras, B.L.; Guenzi, A.; White, S.; Scheel-Fjording, M.; Timmerman, P. Co-medication and interference testing in bioanalysis: a European Bioanalysis Forum recommendation. Bioanalysis 2016, 8, 2065-2070, doi:10.4155/bio-2016-0179. DOI: https://doi.org/10.4155/bio-2016-0179

Wagner-Golbs, A.; Neuber, S.; Kamlage, B.; Christiansen, N.; Bethan, B.; Rennefahrt, U.; Schatz, P.; Lind, L. Effects of Long-Term Storage at −80 °C on the Human Plasma Metabolome. Metabolites 2019, 9, 99, doi:10.3390%2Fmetabo9050099. DOI: https://doi.org/10.3390/metabo9050099

Ayre, A.; Chaudhari, P.; Shaikh, J.; Jagdale, S.; Agrawal, O. Dried matrix spoting-an innovative sample preparation tool in bioanalysis. Int J Pharm Sci Rev Res 2018, 9, 3597-3607. doi:10.13040/IJPSR.0975-8232.9(9).3597-07. DOI: https://doi.org/10.13040/IJPSR.0975-8232.9(9).3597-07

Matuszewski, B.K.; Constanzer, M.L.; Chavez-Eng, C.M. Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MS. Anal. Chem. 2003, 75, 3019-3030, doi:10.1021/ac020361s. DOI: https://doi.org/10.1021/ac020361s

Rudzki, P.J.; Gniazdowska, E.; Buś-Kwaśnik, K. Quantitative evaluation of the matrix effect in bioanalytical methods based on LC-MS: A comparison of two approaches. J Pharm Biomed Anal 2018, 155, 314-319, doi:10.1016/j.jpba.2018.03.052. DOI: https://doi.org/10.1016/j.jpba.2018.03.052

Cortese, M.; Gigliobianco, M.R.; Magnoni, F.; Censi, R.; Di Martino, P. Compensate for or Minimize Matrix Effects? Strategies for Overcoming Matrix Effects in Liquid Chromatography-Mass Spectrometry Technique: A Tutorial Review. Molecules 2020, 25, 3047, doi:10.3390/molecules25133047. DOI: https://doi.org/10.3390/molecules25133047

Xia, Y.Q.; Jemal, M. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects. Rapid Commun Mass Spectrom 2009, 23, 2125-2138, doi:10.1002/rcm.4121. DOI: https://doi.org/10.1002/rcm.4121

Gniazdowska E.M., Giebułtowicz J.,Rudzki P.J. How does the order of sample analysis influence matrix effect during LC-MS bioanalysis? J. Chromatogr. B 2023, 1227, 123800, doi: 10.1016/j.jchromb.2023.123800. DOI: https://doi.org/10.1016/j.jchromb.2023.123800

Amsterdam, P.v.; Companjen, A.; Brudny-Kloeppel, M.; Golob, M.; Luedtke, S.; Timmerman, P. The European Bioanalysis Forum community’s evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation. Bioanalysis 2013, 5, 645-659, doi:10.4155/bio.13.19. DOI: https://doi.org/10.4155/bio.13.19

Ledvina, A.R.; Ewles, M.; Pang, Y.; Cape, S. Whole blood stability in quantitative bioanalysis. Bioanalysis 2019, 11, 1885-1897, doi:10.4155/bio-2019-0155. DOI: https://doi.org/10.4155/bio-2019-0155

Gniazdowska, E.; Goch, W.; Giebułtowicz, J.; Rudzki, P.J. Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach. Molecules 2022, 27, 457, doi:10.3390/molecules27020457. DOI: https://doi.org/10.3390/molecules27020457

DeChenne, S.; Yahvah, K.; Zimmer, J. Validating stability and selectivity in the presence of co-administered compounds. Bioanalysis 2019, 11, 1819-1821, doi:10.4155/bio-2019-0150. DOI: https://doi.org/10.4155/bio-2019-0150

Pu, F.; Zhang, W.; Bateman, K.P.; Liu, Y.; Helmy, R.; Ouyang, Z. Using miniature MS system with automatic blood sampler for preclinical pharmacokinetics study. Bioanalysis 2017, 9,1633-1641, doi:10.4155/bio-2017-0160. DOI: https://doi.org/10.4155/bio-2017-0160

Dillen, L.; Loomans, T.; Perre, G.V.d.; Versweyveld, D.; Wuyts, K.; Zwart, L.d. Blood microsampling using capillaries for drug-exposure determination in early preclinical studies: a beneficial strategy to reduce blood sample volumes. Bioanalysis 2014, 6, 293-306, doi:10.4155/bio.13.286. DOI: https://doi.org/10.4155/bio.13.286

Ingle, R.G.; Zeng, S.; Jiang, H.; Fang, W.-J. Current developments of bioanalytical sample preparation techniques in pharmaceuticals. J Pharm Anal 2022, 12, 517-529, doi:10.1016/j.jpha.2022.03.001. DOI: https://doi.org/10.1016/j.jpha.2022.03.001